Alternatively, Glut1 treatment may promote long-lived memory T cells with the capacity to provide prolonged tumor control, similar to the effects of 2-deoxyglucose and AKT inhibition in models of ACT [154, 155]. This evidence concerns the gene AKT1 and neoplasm.